Business Wire

Leading Streaming Technology Vendors Join Forces to Offer Pre-Integration of Streaming Workflow with Edgio Managed Services

11.9.2023 16:00:00 EEST | Business Wire | Press release

Share

Edgio, together with top streaming technology providers, Accedo, Bitmovin, Grabyo, and Vimond, today announced a strategic partnership to address a growing need faced by media and entertainment when it comes to delivering OTT video – the ability to quickly assemble and manage a streaming ecosystem that delivers high-quality linear, live or on-demand video while reducing costs and increasing efficiencies. Edgio is leading the alliance as a Managed Service Provider, working with companies to seamlessly integrate technologies across the entire streaming tech stack – from content production, personalization and distribution to user experience and monetization. This not only simplifies the intricate processes associated with delivering and managing streaming workflows, it also helps provide a frictionless entry into the market. As managed service provider, Edgio will provide a single point of contact for all support needs, regardless of vendor.

"For media companies, piecing together an ecosystem like this on their own would be costly, time-consuming, and risky," said Eric Black, CTO and GM of Media for Edgio. “By bringing together companies at the forefront of streaming and managing the entire process under one service partner, media companies can focus on creating innovative content versus navigating the complexities of a streaming workflow.”

The pre-integrated workflow provides a winning solution for OTT platforms, broadcasters, sports leagues and content owners: it delivers on their desire to increase profitability, while supporting the very best in viewer experience, no matter what type of content a viewer is watching or on what device — all while reducing internal costs and operational complexity. The increased flexibility empowers customers to experiment with distribution and price point models, such as AVOD, SVOD, and FAST, to find the most profitable individualized offering for their specific audiences.

At launch, the partner ecosystem includes:

  • Accedo: App Development
    Media companies can ensure a consistent, high-quality representation of their brand across all streaming touchpoints with Video Application management, which includes custom templates and bespoke development for state-of-the-art UX that attracts and retains users. Accedo is pre-integrated with Vimond and Bitmovin to provide a seamless end-to-end solution.
  • Bitmovin: Video Player + Analytics
    The Bitmovin Player empowers media organizations to guarantee flawless playback and viewing experiences across an extensive range of devices at speed and scale. Bitmovin Analytics ensures stream reliability by user session data and pinpointing any playback issues in real-time so they can be resolved before they impact the viewer. Bitmovin’s Analytics delivers real-time operational monitoring to optimize video and ad workflows based on viewer experiences across all platforms. Bitmovin Analytics also offers benchmarks across different performance metrics to gain industry insights.
  • Edgio: Uplynk Platform, CDN Delivery, and Managed Service Provider
    Uplynk empowers media companies to deliver the highest-quality streaming experiences to global audiences, while reducing time-to-market and driving operational scale. Its best-in-class components deliver exceptional viewing quality and reliability while maximizing monetization through advanced advertising. Uplynk, coupled with Edgio’s expert services, provides an exceptionally quick time-to-market and improves ROI. The Uplynk platform will be the foundation through which the OTT ecosystem is built upon using a mix of open standard video protocols and flexible APIs.
  • Grabyo: Clipping & Live Production
    Grabyo is a modern, cloud-native SaaS solution for live production, video clipping, real-time editing and distribution. The platform can scale from single operator digital streams to multi-camera productions with a larger remote team, combined with integrated live clipping, editing and publishing tools. With the recent introduction of SCTE-35 marker insertion, Grabyo’s cloud production users can now create ad breaks to monetize their live video across linear broadcast, FAST and OTT platforms. The platform supports live feeds from on-site cameras, audio sources, remote guests or mobile field kits, with ingest streams up to 50Mbps, 1080p/60FPS using leading video protocols including SRT, Zixi, RIST, RTMPs, HLS and RTP. Grabyo provides unlimited capacity for live video clipping and will sit in front of Uplynk, so customers can ingest video with Grabyo then publish to Uplynk where it’s distributed to end viewers.
  • Vimond: Content Management System (CMS)
    Vimond’s CMS enables customers to provide contextual metadata to describe and curate content presented to users in apps and websites. With support across the workflow, from media ingest, asset management, metadata enrichment, to distribution, Vimond VIA provides customers with a flexible and user-friendly CMS to handle videos, freeing valuable resources to focus on winning new viewers and content strategy. Vimond’s VIA product will use Uplynk as its backend video management system by integrating with Uplynk APIs.

Each of the companies will be demonstrating their technologies this week at IBC2023, RAI Amsterdam, September 15-18, 2023. Accedo: Hall 5, Stand F40; Bitmovin Hall 5, stand D72; Edgio, Hall 5 stand F18; Grabyo, Hall 5, Stand A20; Vimond, Hall 5, Stand H59.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Sally Winship Comollo, Edgio
swinship-comollo@edg.io
+1 781-366-5590

Bleuenn Le Goffic, Accedo
bleuenn.legoffic@accedo.tv

Zoe Mumba, Bitmovin
zoe.mumba@bitmovin.com

Scott Lunn, Grabyo
scott@grabyo.com

Fredrik Gunnestad, CEO, Vimond Media Solutions
fredrik@vimond.com / LinkedIn

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye